These findings suggest the upregulation of the type 1 IFN system through the activation of monocytes, macrophages, or other immunocompetent cells in the pathophysiology of anti-MDA5-positive DM with RP-ILD (59). The gene discussed is IFIH1; the disease is interstitial lung disease.